Neil Palmisiano appointed deputy director of phase I therapeutics for hematologic malignancies at Rutgers

RWJBarnabas Health and Rutgers Cancer Institute open breast health center in East Brunswick

RWJBarnabas Health and Rutgers Cancer Institute opened a new Breast Health Center in East Brunswick, NJ.

March 07, 2025

Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

Kimberly Stegmaier was named chair of Pediatric Oncology at Dana-Farber Cancer Institute and associate chief of the Division of Hematology/Oncology at Boston Children’s Hospital. Her appointment is effective April 1.

February 21, 2025

Vol.51 No.07

In Brief

Jason Damsker and Michael Noonan join Fox Chase

Jason A. DamskerMichael NoonanJason A. Damsker was appointed professor in the Department of Hematology/Oncology and Michael Noonan was appointed assistant professor in the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center.

February 21, 2025

Vol.51 No.07

Clinical Trials & Tribulations

Chadi Nabhan: Why I wrote a book about cancer

Almost all of us who have practiced oncology for years have encountered situations where we have had to counsel caregivers and guide them throughout their loved ones’ journeys. We have faced patients who took complementary therapies to an extreme; some to a point where they wouldn’t share what they were taking for fear that we might demand they stop.

Jennifer Woyach named director of OSUCCC—James’s Division of Hematology

Jennifer A. Woyach, a blood cancer doctor and researcher who has been with Ohio State for more than 12 years, was named director of the Division of Hematology at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

January 17, 2025

Vol.51 No.02

In Brief

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

Neil Palmisiano appointed deputy director of phase I therapeutics for hematologic malignancies at Rutgers

YOU MAY BE INTERESTED IN

RWJBarnabas Health and Rutgers Cancer Institute open breast health center in East Brunswick

Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

Jason Damsker and Michael Noonan join Fox Chase

Chadi Nabhan: Why I wrote a book about cancer

Jennifer Woyach named director of OSUCCC—James’s Division of Hematology

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Renew today!

Subscriber content